Swati Mbbs Lakra
Research Subjects
Research Interests
Swati Mbbs Lakra has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Agha Muhammad Wali Mirza
Department of Internal Medicine, Jinnah Medical and Dental College, Karachi, Pakistan
1 shared publication - Arshiya Mbbs Adhnon
Department of Internal Medicine, Dubai Medical College for Girls, Dubai, United Arab Emirates
1 shared publication - Hareem Mbbs Fatima
Department of Internal Medicine, Federal Medical College, Islamabad, Pakistan
1 shared publication - Ivo W. Mbbs Filho
Department of Internal Medicine, Faculdade Pernambucana de Saúde (FPS), Recife, Brazil
1 shared publication - Kamal Kandel
Department of Medicine Kathmandu University Dhulikhel Nepal
1 shared publication - Mahendra Mbbs Kumar
Department of Internal Medicine, Sardar Patel Medical College, Bikaner, Rajasthan
1 shared publication
Latest Publications
- Open Access
- 14 August 2024
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 86 (11) , 6665-6672
Effect of vitamin D supplementation on cardiovascular outcomes: an updated meta-analysis of RCTs
Objective: To evaluate the effect of vitamin D supplementation on cardiovascular outcomes. Methods: After searching different databases, we retrieved and included randomized controlled trials on long-term supplementation of vitamin D (≥1-year intervention) and reporting cardiovascular outcomes. We calculated risk ratio (RR) with 95% confidence intervals (CI) for dichotomous outcomes. Results: Compared to the control group, the vitamin D group was not associated with a statistically significant decrease in the incidence of major adverse cardiovascular events (MACE) [risk ratio=0.99; 95% CI: 0.94–1.03]. We found no difference between the vitamin D group and the control group for the outcomes of incidences of myocardial infarction, heart failure, coronary revascularization, cardiovascular death, and all-cause mortality. The heterogeneity was low for all outcomes. Conclusion: According to our meta-analysis, vitamin D supplementation did not reduce major adverse cardiovascular events, other cardiovascular parameters, and all-cause mortality.
- 14 August 2024
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 86 (11) , 6665-6672
Open AccessEffect of vitamin D supplementation on cardiovascular outcomes: an updated meta-analysis of RCTs
Objective: To evaluate the effect of vitamin D supplementation on cardiovascular outcomes. Methods: After searching different databases, we retrieved and included randomized controlled trials on long-term supplementation of vitamin D (≥1-year intervention) and reporting cardiovascular outcomes. We calculated risk ratio (RR) with 95% confidence intervals (CI) for dichotomous outcomes. Results: Compared to the control group, the vitamin D group was not associated with a statistically significant decrease in the incidence of major adverse cardiovascular events (MACE) [risk ratio=0.99; 95% CI: 0.94–1.03]. We found no difference between the vitamin D group and the control group for the outcomes of incidences of myocardial infarction, heart failure, coronary revascularization, cardiovascular death, and all-cause mortality. The heterogeneity was low for all outcomes. Conclusion: According to our meta-analysis, vitamin D supplementation did not reduce major adverse cardiovascular events, other cardiovascular parameters, and all-cause mortality.